Table 1 Baseline, anthropometric, laboratory, and clinical characteristics of subjects.
From: Severe nocturnal cardiac arrhythmias caused by sleep apnea-induced hypoxemia in males
SAH (+) n = 33 | SAHS (-) n = 16 | P | |
|---|---|---|---|
Age (yr) | 52 ± 8 | 48 ± 11 | NS |
BMI (kg/m2) | 28.9 ± 4.4 | 29.7 ± 4.4 | NS |
Waist circumference (cm) | 102 ± 10 | 100 ± 12 | NS |
Total cholesterol (mmol/l) | 5.5 ± 1.01 | 5.1 ± 0.8 | NS |
TriAcylGlyc (mmol/l) | 2.6 ± 3.9 | 1.9 ± 0.9 | NS |
HDL-chol (mmol/l) | 1.2 ± 0.3 | 1.2 ± 0.3 | NS |
LDL-chol (mmol/l) | 3.7 ± 1.2 | 3.1 ± 0.7 | NS |
Glycemia (mmol/l) | 5.6 ± 0.8 | 5.6 ± 1.2 | NS |
Age risk (≥ 45 years) (n/%) | 28/85 | 9/56 | NS |
Positive family history (n/%) | 7/21 | 2/13 | NS |
AH (n/%) | 21/64 | 7/44 | NS |
DM (n/%) | 2/6 | 3/19 | NS |
HLP (n/%) | 18/55 | 9/56 | NS |
Obesity (BMI) (n/%) | 9/27 | 6/38 | NS |
Central obesity (Waist) (n/%) | 14/42 | 7/44 | NS |
Smoking (n/%) | 19/58 | 10/63 | NS |
ACE inhibitors (n/%) | 11/33 | 5/31 | NS |
Beta-blockers (n/%) | 11/33 | 9/56 | NS |
Ca-channel blockers (n/%) | 10/30 | 4/25 | NS |